Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market
FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market
FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market
Submitted by
admin
on February 17, 2018 - 10:44am
Source:
Endpoints
News Tags:
FDA
AstraZeneca
Imfinzi
lung cancer
Bavencio
Pfizer
Merck KGaA
Headline:
FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market
Do Not Allow Advertisers to Use My Personal information
